Literature DB >> 17255328

Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice.

Ping Li1, Richard E Waters, Shelley I Redfern, Mei Zhang, Lan Mao, Brian H Annex, Zhen Yan.   

Abstract

The fiber specificity of skeletal muscle abnormalities in chronic heart failure (CHF) has not been defined. We show here that transgenic mice (8 weeks old) with cardiac-specific overexpression of calsequestrin developed CHF (50.9% decrease in fractional shortening and 56.4% increase in lung weight, P<0.001), cachexia (37.8% decrease in body weight, P<0.001), and exercise intolerance (69.3% decrease in running distance to exhaustion, P<0.001) without a significant change in muscle fiber-type composition. Slow oxidative soleus muscle maintained muscle mass, whereas fast glycolytic tibialis anterior and plantaris muscles underwent atrophy (11.6 and 13.3%, respectively; P<0.05). In plantaris muscle, glycolytic type IId/x and IIb, but not oxidative type I and IIa, fibers displayed significant decreases in cross-sectional area (20.3%, P<0.05). Fast glycolytic white vastus lateralis muscle showed sarcomere degeneration and decreased cytochrome c oxidase IV (39.5%, P<0.01) and peroxisome proliferator-activated receptor gamma co-activator 1alpha protein expression (30.3%, P<0.01) along with a dramatic induction of the MAFbx/Atrogin-1 mRNA. These findings suggest that exercise intolerance can occur in CHF without fiber type switching in skeletal muscle and that oxidative phenotype renders myofibers resistant to pathological insults induced by CHF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255328      PMCID: PMC1851852          DOI: 10.2353/ajpath.2007.060505

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Fiber size and myosin phenotypes of selected Rhesus hindlimb muscles after a 14-day spaceflight.

Authors:  R R Roy; S C Bodine; D J Pierotti; J A Kim; R J Talmadge; G Barkhoudarian; J W Fanton; I Koslovskaya; V R Edgerton
Journal:  J Gravit Physiol       Date:  1999-10

2.  Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle.

Authors:  E De Sousa; V Veksler; X Bigard; P Mateo; R Ventura-Clapier
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

Review 3.  Exercise limitation in chronic heart failure: central role of the periphery.

Authors:  A L Clark; P A Poole-Wilson; A J Coats
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

4.  Differences in skeletal muscle between men and women with chronic heart failure.

Authors:  B D Duscha; B H Annex; S J Keteyian; H J Green; M J Sullivan; G P Samsa; C A Brawner; F H Schachat; W E Kraus
Journal:  J Appl Physiol (1985)       Date:  2001-01

5.  Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy.

Authors:  A Rapacciuolo; G Esposito; K Caron; L Mao; S A Thomas; H A Rockman
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

7.  Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure.

Authors:  L Dalla Libera; B Ravara; A Angelini; K Rossini; M Sandri; G Thiene; G Battista Ambrosio; G Vescovo
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

8.  mRNA distribution analysis of human TRPC family in CNS and peripheral tissues.

Authors:  Antonio Riccio; Andrew D Medhurst; Cesar Mattei; Rosemary E Kelsell; Andrew R Calver; Andrew D Randall; Christopher D Benham; Menelas N Pangalos
Journal:  Brain Res Mol Brain Res       Date:  2002-12-30

9.  Differential effects of exercise training in men and women with chronic heart failure.

Authors:  Steven J Keteyian; Brian D Duscha; Clinton A Brawner; Howie J Green; Charles R c Marks; Fred H Schachat; Brian H Annex; William E Kraus
Journal:  Am Heart J       Date:  2003-05       Impact factor: 4.749

10.  PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure.

Authors:  Steven Reiken; Alain Lacampagne; Hua Zhou; Aftab Kherani; Stephan E Lehnart; Chris Ward; Fannie Huang; Marta Gaburjakova; Jana Gaburjakova; Nora Rosemblit; Michelle S Warren; Kun-Lun He; Geng-Hua Yi; Jie Wang; Daniel Burkhoff; Guy Vassort; Andrew R Marks
Journal:  J Cell Biol       Date:  2003-03-10       Impact factor: 10.539

View more
  47 in total

Review 1.  Metabolic benefits of resistance training and fast glycolytic skeletal muscle.

Authors:  Nathan K LeBrasseur; Kenneth Walsh; Zoltan Arany
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-02       Impact factor: 4.310

Review 2.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

3.  Heart failure increases atrogin-1 and MuRF1 gene expression in skeletal muscle with fiber type-specific atrophy.

Authors:  Robson Francisco Carvalho; Eduardo Paulino Castan; Cesar Augusto Coelho; Francis Silva Lopes; Fernanda Losi Alves Almeida; Aline Michelin; Rodrigo Wagner Alves de Souza; João Pessoa Araújo; Antonio Carlos Cicogna; Maeli Dal Pai-Silva
Journal:  J Mol Histol       Date:  2010-03-28       Impact factor: 2.611

4.  Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB.

Authors:  Soichiro Usui; Yasuhiro Maejima; Jayashree Pain; Chull Hong; Jaeyeaon Cho; Ji Yeon Park; Daniela Zablocki; Bin Tian; David J Glass; Junichi Sadoshima
Journal:  Circ Res       Date:  2011-05-26       Impact factor: 17.367

5.  Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexia.

Authors:  Maria Lima; Shuichi Sato; Reilly T Enos; John W Baynes; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2013-01-17

6.  Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.

Authors:  Mitsuharu Okutsu; Jarrod A Call; Vitor A Lira; Mei Zhang; Jean A Donet; Brent A French; Kyle S Martin; Shayn M Peirce-Cottler; Christopher M Rembold; Brian H Annex; Zhen Yan
Journal:  Circ Heart Fail       Date:  2014-02-12       Impact factor: 8.790

7.  Myocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia.

Authors:  Surovi Hazarika; Michael Angelo; Yongjun Li; Amy J Aldrich; Shelley I Odronic; Zhen Yan; Jonathan S Stamler; Brian H Annex
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-25       Impact factor: 8.311

8.  p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting.

Authors:  J M McClung; A R Judge; S K Powers; Z Yan
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-02       Impact factor: 4.249

9.  Eccentric contraction-induced myofiber growth in tumor-bearing mice.

Authors:  Justin P Hardee; Joshua E Mangum; Song Gao; Shuichi Sato; Kimbell L Hetzler; Melissa J Puppa; Dennis K Fix; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2015-10-22

10.  Cancer cachexia decreases specific force and accelerates fatigue in limb muscle.

Authors:  B M Roberts; G S Frye; B Ahn; L F Ferreira; A R Judge
Journal:  Biochem Biophys Res Commun       Date:  2013-05-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.